We use cookies to enhance your experience, for analytics & personalisation. We share information about the use of our site with our trusted partners. If you click the "Accept" button you agree to having these cookies set on your device. By continuing to use our site, we assume that you consent to receive all necessary tracking cookies from us. You can adjust your browser settings to control cookies. Find out more here.

southampton science park business growth

Securing investment

Renovos, one of the residents Southampton Science Park, has won further funding to develop its ground-breaking nanoclay technology.

The company’s latest award is via the highly competitive SMART competition run by Innovate UK, the UK’s innovation agency. SMART grants fund ambitious or disruptive innovations that can make a significant impact on the UK economy. The news follows an announcement earlier this year that Renovos was the first company to receive investment from a newly launched Ronald Furlong Fund, set up by the charity Orthopaedic Research UK.

The funding will enable Renovos to further develop its pioneering use of synthetic nanoclays in regenerative medicine and accelerate its path to regulatory approval. The technology allows a 100x lower dose of regenerative therapeutic agent to be precisely delivered and localised to the sites where needed, fundamentally changing the way extremely powerful and sometimes harmful drugs are given around bone.

Renovos technology has attracted significant investor attention since its inception just three years ago. The company’s Founder and CEO, Agnieszka Janeczek, spoke recently of her experiences of securing investment in Southampton Science Park’s SO Magazine. 

Related news from
around the Park

Book a meeting space

We have 11 meeting rooms all of which can be configured in a number of different ways to cater for your meeting or event. Please use the two links below to book a meeting room either as a tenant or a visitor to the University of Southampton Science Park

View terms & conditions here.